Trump announces nine new drug pricing deals with manufacturers

President Trump announced nine additional drug pricing agreements with manufacturers, expanding his administration's push to lower prescription costs. The deals follow earlier rounds and signal continued pressure on pharmaceutical pricing, though specific terms and affected drugs remain undisclosed. This development matters for pharmaceutical sector margins and broader healthcare policy direction.